“Bladder Cancer Diagnosis and Monitoring Based on Urine Survivin (BIRC5) Bioluminescence-Based Immunoassay”. Voprosy Onkologii, vol. 72, no. 2, May 2026, p. OF-2510, https://doi.org/10.37469/0507-3758-2026-72-2-OF-2510.